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Signaling pathways for cellular metabolism, growth, proliferation, differentiation, immune 
response, motility, and tissue homeostasis is regulated by the phosphorylation of 
protein tyrosine residues on target proteins in the relevant signal transduction pathways. 
Phosphorylation levels of tyrosine residues are controlled by the opposing actions of 
two enzymes: protein tyrosine kinases and protein tyrosine phosphatases (PTPs). 
Protein tyrosine kinases add phosphoryl groups while PTPs catalyze their removal. 
PTPs are emerging as potential drug targets for the treatment of type 2 diabetes, 
autoimmune diseases, osteoporosis, and cancer. PTP-1B is the archetypal PTP and its 
inactivation may be a viable treatment for type 2 diabetes and obesity. PTP-1B is 
regulated by endogenous hydrogen peroxide (H2O2), which is a known cellular 
signaling agent. H2O2 oxidatively-inactivates PTP-1B, and its activity is regenerated by 
free thiols within the cell such as glutathione. In order to facilitate enzyme regeneration 
the aforementioned thiol must have access to the enzyme active site. We are testing the 
hypothesis that small molecules can inhibit thiol-mediated reactivation of redox-
inactivated PTPs. Molecules with such a property would decrease the activity of target 
PTPs in cells, thus enhancing cellular response to external stimuli that act through 
receptor protein kinases.  
 
